Linical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
1,608
1,756
2,911
4,355
5,173
5,056
Total Accounts Receivable
635
1,178
1,682
1,261
1,344
1,564
Inventories
1
-
-
-
-
-
Other Current Assets
143
467
518
596
638
1,104
Total Current Assets
2,387
3,401
5,111
6,213
7,155
7,724
Net Property, Plant & Equipment
38
53
79
74
106
134
Total Investments and Advances
230
360
366
646
209
269
Intangible Assets
147
1,756
1,469
1,263
1,238
4,461
Other Assets
3
3
16
1
421
446
Total Assets
2,836
5,642
7,122
8,300
9,247
13,259
ST Debt & Current Portion LT Debt
35
512
166
188
143
Income Tax Payable
76
229
537
312
267
Other Current Liabilities
402
1,320
1,951
2,376
2,377
Total Current Liabilities
513
2,060
2,654
2,876
2,787
Long-Term Debt
377
1,219
1,100
941
798
Provision for Risks & Charges
94
236
280
341
421
Deferred Taxes
32
3
22
57
83
Other Liabilities
-
-
14
-
5
Total Liabilities
985
3,582
4,105
4,204
4,048
Common Equity (Total)
1,852
2,061
3,017
4,096
5,205
Total Shareholders' Equity
1,852
2,061
3,017
4,096
5,205
Total Equity
1,852
2,061
3,017
4,096
5,205
Liabilities & Shareholders' Equity
2,836
5,642
7,122
8,300
9,252

About Linical Co.

View Profile
Address
Shin-Osaka Brick Building, 10/F
Osaka Osaka 532
Japan
Employees -
Website http://www.linical.co.jp
Updated 07/08/2019
Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. It operates through the Contract Research Organization (CRO) Business and Contract Sales Organization (CSO) Business segments. The CRO Business segment provides outsourced pharmaceutical development services.